Credit Suisse’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$38.1M Buy
1,844,796
+88,461
+5% +$1.82M 0.04% 441
2023
Q4
$47.5M Buy
1,756,335
+39,827
+2% +$1.08M 0.05% 398
2023
Q3
$50.9M Sell
1,716,508
-475,213
-22% -$14.1M 0.05% 363
2023
Q2
$78.5M Buy
2,191,721
+43,850
+2% +$1.57M 0.08% 260
2023
Q1
$50.3M Buy
2,147,871
+36,828
+2% +$863K 0.05% 390
2022
Q4
$57.4M Buy
2,111,043
+301,890
+17% +$8.21M 0.06% 337
2022
Q3
$97.4M Sell
1,809,153
-625
-0% -$33.6K 0.11% 190
2022
Q2
$73M Sell
1,809,778
-8,165
-0.4% -$329K 0.08% 270
2022
Q1
$120M Buy
1,817,943
+7,922
+0.4% +$525K 0.1% 206
2021
Q4
$181M Buy
1,810,021
+19,946
+1% +$2M 0.1% 149
2021
Q3
$224M Buy
1,790,075
+4,317
+0.2% +$540K 0.12% 114
2021
Q2
$222M Buy
1,785,758
+32,313
+2% +$4.01M 0.12% 132
2021
Q1
$268M Buy
1,753,445
+113,127
+7% +$17.3M 0.14% 99
2020
Q4
$211M Buy
1,640,318
+157,003
+11% +$20.2M 0.1% 136
2020
Q3
$166M Buy
1,483,315
+82,954
+6% +$9.27M 0.1% 138
2020
Q2
$114M Buy
1,400,361
+549,597
+65% +$44.6M 0.08% 200
2020
Q1
$59.2M Buy
850,764
+96,710
+13% +$6.73M 0.05% 300
2019
Q4
$58.9M Buy
754,054
+178,873
+31% +$14M 0.04% 350
2019
Q3
$36.7M Buy
575,181
+58,945
+11% +$3.76M 0.03% 452
2019
Q2
$44.6M Buy
516,236
+82,197
+19% +$7.1M 0.04% 378
2019
Q1
$33.3M Sell
434,039
-8,416
-2% -$646K 0.03% 463
2018
Q4
$16.6M Buy
+442,455
New +$16.6M 0.02% 721